Dong-A Pharmaceutical Hosts 2025 Pharmacist Academic Symposium 'NEW RISE'

Academic Presentations and Sharing of Latest Insights

Dong-A Pharmaceutical announced on the 18th that it had hosted the 2025 Pharmacist Academic Symposium 'NEW RISE'.

The 2025 Pharmacist Academic Symposium 'NEW RISE' hosted by Dong-A Pharmaceutical. Dong-A Pharmaceutical

The slogan of this symposium, 'NEW RISE', conveys Dong-A Pharmaceutical's vision for a new leap forward and innovation in its over-the-counter (OTC) medicines. The symposium was held sequentially in three major cities-Seoul, Busan, and Daejeon-and was attended in person by approximately 500 pharmacists.

The event was divided into two sessions, sharing academic information and the latest insights on Dong-A Pharmaceutical's flagship OTC products: the degenerative arthritis treatment 'Max Chondroitin 1200' and the high-content pidolate magnesium complex 'Magrangbi'.

In the first session, Sunhye Kim, a pharmacist at Sanga Pharmacy, gave a presentation titled "Treat Your Joints with Medicine Now! Max Chondroitin 1200," introducing the joint improvement effects based on clinical evidence for 1,200mg of chondroitin. Kim explained, "Max Chondroitin 1200 is an OTC medicine containing 1,200mg of KP-standard chondroitin as its active ingredient, and it is clearly distinguished from health functional foods using the same ingredient in terms of active content, formulation stability, and clinical evidence. Since a sufficient effective dose can be achieved with just one daily dose, this is a key point pharmacists can highlight when counseling for continued use."

In the second session, Dr. Sungkon Oh of the Pharmacy Practice Research Institute presented on "Pidolate Magnesium Complexes with Different Absorption Rates," introducing the absorption mechanism of pidolate magnesium, the main ingredient of Magrangbi, and its features based on clinical evidence published in SCI-level journals. Dr. Oh stated, "Magrangbi is the first OTC product in Korea to use pidolate magnesium, a chelated form of magnesium, as its main ingredient. It is a next-generation active magnesium formulation that not only offers high absorption and bioavailability, but also reduces gastrointestinal burden."

A representative from Dong-A Pharmaceutical commented, "This symposium went beyond simple product promotion and aimed to enhance the credibility of Dong-A Pharmaceutical's OTC products through academic exchange with pharmacists."

This content was produced with the assistance of AI translation services.